Role of immunohistochemical markers in evaluating malignant transformation of oral submucous fibrosis: A systematic review

Nidhi Sharma; Madhuri Gawande; Minal Chaudhary; Fatema Saify; Swati Patil; Bharat Gupta

doi:10.53730/ijhs.v6nS1.4839

Authors

Nidhi Sharma
dr.nidhisharma@yahoo.com
Associate professor, Department of Oral Pathology and Microbiology, Government Dental College, Raipur, C.G, India
Madhuri Gawande Prof. and HOD, Department of Oral Pathology and Microbiology, SPDC, Sawangi, Wardha, India
Minal Chaudhary Director Examination, Assessment and Evaluation, Dutta Meghe Institution of Medical Science (Deemed to be University), Nagpur (MS), India
Fatema Saify Associate Professor, Department of Oral Pathology and Microbiology, Government Dental College, Raipur, C.G, India
Swati Patil Associate professor, Department of Oral Pathology and Microbiology, SPDC, Sawangi, Wardha, India
Bharat Gupta Associate Professor, Department of Periodontics, MGM Dental College, NAVI Mumbai, India

Keywords:

COX2, e-cadherin, oral submucous fibrosis, ?-SMA, ?-catenin

Abstract

Objective(s): We present a systematically to identify, evaluate and assess the role of Immunohistochemical markers in Malignant Transformation of Oral Submucous Fibrosis (OSF). Materials and Methods: Extensive literature search was done to identify eligible through “MEDLINE”/ “PubMed”, “Scopus” and “Cochrane library” were searched for relative studies until December 2021. The included studies were published in English language were mainly retrospective original research\.These studies mainly evaluated the role of Immunohistochemical markers in Malignant Transformation of Oral Submucous Fibrosis. Results: Thirteen studies were included in the present study which had total of 549 cases. Most of the studies suggested use of combined biomarker model or panel of antibodies to minimize the risk of bias. Almost all the studies used ANOVA and chi-square test while kappa test analysis for interobserver variability test. Conclusions: The significance of immunohistochemical markers has been shown in study which can significantly contribute in diagnosing early event in process of malignant transformation of suspicious OSF cases so that better treatment plan could be formulated for better prognosis. More efforts should be emphasized on combination of \antibodies and its importance in target drug therapy.

Downloads

Download data is not yet available.

References

Bavle, R. M., Paremala, K., Sowmya, M., Sudhakara, M., Reshma, V., & Hosthor, S. (2020). Predicting the malignant transformation of oral submucous fibrosis using quantitative biomarkers p63 and CD31. Journal of Orofacial Sciences, 12(1), 52.

Bazarsad, S., Zhang, X., Kim, K. Y., Illeperuma, R., Jayasinghe, R. D., Tilakaratne, W. M., & Kim, J. (2017). Identification of a combined biomarker for malignant transformation in oral submucous fibrosis. Journal of Oral Pathology & Medicine, 46(6), 431-438.

Chowdhury, P., Nagamalini, B. R., Singh, J., & Ashwini, B. K. (2021). Expression of ?-catenin in oral leukoplakia and oral submucous fibrosis: An immunohistochemical study. Journal of Oral and Maxillofacial Pathology: JOMFP, 25(1), 124.

Divyambika, C. V., Sathasivasubramanian, S., Vidyarani, S., RaviDavid, A., Harinee, S., & Vijayalakshmi, R. (2021). Clinicopathological correlation of cyclooxygenase 2 expression in oral submucous fibrosis: An immunohistochemical study. Journal of International Society of Preventive & Community Dentistry, 11(5), 553.

Ekanayaka, R. P., & Tilakaratne, W. M. (2016). Oral submucous fibrosis: review on mechanisms of malignant transformation. Oral surgery, oral medicine, oral pathology and oral radiology, 122(2), 192-199.

Hosur, M. B., Puranik, R. S., Vanaki, S. S., Puranik, S. R., Sudhakara, M., & Das, S. (2021). Evaluation of immunohistochemical expression of epithelial–mesenchymal transition markers E-cadherin, Twist and Snail in oral submucous fibrosis and their possible association with malignant transformation. Journal of Oral and Maxillofacial Pathology: JOMFP, 25(1), 97.

Joseph, I., Elizabeth, J., Rao, U. K., & Ranganathan, K. (2020). Study of Hypoxia-inducible factor-2? expression in the malignant transformation of Oral submucous fibrosis. Journal of Oral and Maxillofacial Pathology: JOMFP, 24(1), 33.

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg, 8(5), 336-341.

Monteiro, R., Hallikeri, K., & Sudhakaran, A. (2021). PTEN and ?-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis. Journal of oral & maxillofacial research, 12(1).

Nithya, S., Joshua, E., Ranganathan, K., Thavarajah, R., & Rao, U. K. (2019). Loricrin expression and its implication in oral submucous fibrosis, hyperkeratosis and normal mucosa with association to habits–An immunohistochemical study. Journal of Oral Biology and Craniofacial Research, 9(3), 226-231.

Patel, P. N., Thennavan, A., Sen, S., Chandrashekar, C., & Radhakrishnan, R. (2015). Translational approach utilizing COX-2, p53, and MDM2 expressions in malignant transformation of oral submucous fibrosis. Journal of oral science, 57(3), 169-176.

Quan, H., Liu, S., Shan, Z., Liu, Z., Chen, T., Hu, Y., ... & Fang, L. (2020). Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis. Archives of Oral Biology, 119, 104916.

Raju K, L., Haragannavar, V. C., Patil, S., Rao, R. S., Nagaraj, T., Augustine, D., ... & Nambiar, S. (2020). Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma–an Immunohistochemical Analysis. Pathology & Oncology Research, 26(3), 1573-1582.

Sharada, P., Swaminathan, U., Nagamalini, B. R., Kumar, K. V., Ashwini, B. K., & Lavanya, V. L. N. (2018). Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders. Journal of oral and maxillofacial pathology: JOMFP, 22(1), 40.

Sudarshan, R., & Annigeri, R. G. (2012). Pathogenesis of oral submucous fibrosis: The past and current concepts. International Journal of Oral & Maxillofacial Pathology, 3(2), 27-37.